1Lane DP, Crawford LV. T antigen is bound to a host proteinin SV40-transformed cells[J]. Nature, 1979,278: 261-263.
2Finlay CA,Hinds PW, Levine AJ. The p53 proto-oncogenecan act as a suppressor of transformation[J]. Cell,1989,57:1083-1093.
3Freed-Pastor WA,Prives C. Mutant p53 : one name, manyproteins[J]. Genes Dev, 2012,26: 1268-1286.
4Efeyan A,Serrano M. p53 : guardian of the genome and po-liceman of the oncogenes [J]. Cell Cycle, 2007,6: 1006-1010.
5Bossi G, Lapi E,Strano S,et al. Mutant p53 gain of func-tion: reduction of tumor malignancy of human cancer celllines through abrogation of mutant p53 expression[J]. Onco-gene, 2006,25: 304-309.
6Knappskog S,Lonning PE. P53 and its molecular basis tochemoresistance in breast cancer[J]. Expert Opin Ther Tar-gets, 2012,16: S23-S30.
7Liang Y,Besch-Williford C, Hyder SM. PRIMA-1 inhibitsgrowth of breast cancer cells by re-activating mutant p53 pro-tein[J], Int J Oncol, 2009, 35: 1015-1023.
8Rehman A, Chahal MS,Tang X,et al. Proteomic identifica-tion of heat shock protein 90 as a candidate target for p53 mu-tation reactivation by PRIMA-1 in breast cancer ceils[J].Breast Cancer Res, 2005, 7: R765-R774.
9Bykov VJ,Issaeva N,Zache N,etal. Reactivation of mutantp53 and induction of apoptosis in human tumor cells by male-imide analogs[J]. J Biol Chem, 2005,280: 30384-30391.
10Takimoto R,Wang W, Dicker DT,et al. The mutant p53-conformation modifying drug,CP-31398, can induce apopto-sis of human cancer cells and can stabilize wild-type p53 pro-tein[J]. Cancer Biol Ther, 2002,1: 47-55.
